8-K: Co-Diagnostics Fails to Achieve Quorum Again

Co-Diagnostics, Inc. announced the adjournment of its Annual Meeting of Stockholders for a second time due to a failure to achieve a quorum, rescheduling for September 30, 2026.

Summary

• Co-Diagnostics, Inc. held its Annual Meeting of Stockholders on September 3, 2026, but failed to achieve a quorum and thus could not conduct business.
• The meeting was adjourned to September 24, 2026.
• On September 24, 2026, the adjourned meeting was held, but again, a quorum was not achieved.
• The Annual Meeting has been further adjourned to September 30, 2026, at 9:00 a.m. Mountain Time, to be held at the company's offices.
• Stockholders are deemed to be present and vote as disclosed in the definitive proxy statement filed on July 21, 2026.
• Valid proxies submitted prior to the reconvened meeting remain valid unless revoked.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the repeated failure to achieve a quorum, indicating potential shareholder disengagement or unresolved issues.

Negatives

• The company has failed to achieve a quorum at its Annual Meeting of Stockholders on two separate occasions (September 3 and September 24, 2026).
• This repeated failure to achieve a quorum prevents the transaction of any business at the meeting.

Risks

• Continued failure to achieve a quorum could lead to governance issues and potential challenges in making necessary corporate decisions.
• Shareholder apathy or dissatisfaction may be indicated by the inability to reach a quorum, potentially impacting future engagement and support.

Future Outlook

The company is proceeding with a further adjournment of the Annual Meeting to September 30, 2026, with the expectation that a quorum will be met at that time. The company will continue to rely on previously submitted proxies.

Management Comments

• Pursuant to the Company's bylaws, if a quorum is not present or represented at any meeting of the stockholders, the chairperson of the meeting has the power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present or represented.

Industry Context

StockSavvy.ai notes that achieving a quorum at shareholder meetings is a fundamental aspect of corporate governance. Repeated failures can signal underlying issues with shareholder engagement, communication, or unresolved concerns that may be preventing participation.

Corporate Governance

Stakeholder Impact

• Shareholders: May experience frustration or concern over the inability to conduct company business and potential governance issues. Their voting power is currently not being fully utilized due to the lack of quorum.
• Management: Faces challenges in moving forward with corporate decisions that require shareholder approval.

Next Steps

• Hold the adjourned Annual Meeting of Stockholders on September 30, 2026.
• Ensure a quorum is present or represented at the September 30, 2026 meeting to conduct business.

Key Dates

Keywords

Annual Meeting, Stockholders, Quorum, Adjournment, Corporate Governance, Proxy Statement